Chan et al. showed that AQP4 + NMO did not have significantly different outcomes from multiple sclerosis and idiopathic optic neuritis in a PLEX cohort, even after controlling for age, gender, severity of vision loss at nadir and time to PLEX treatment [31]. The gene discussed is AQP4; the disease is multiple sclerosis.